Amneal Pharmaceuticals, Inc. AMRX Payments to Acquire Intangible Assets
Payments to Acquire Intangible Assets at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s payments to acquire intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s payments to acquire intangible assets?
- Amneal Pharmaceuticals, Inc. (AMRX) reported payments to acquire intangible assets of $7.85M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s payments to acquire intangible assets changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s payments to acquire intangible assets increased by 86.9% year-over-year, from $4.2M to $7.85M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s payments to acquire intangible assets?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s payments to acquire intangible assets has grown at a 73.8% compound annual growth rate (CAGR), from $1.7M to $15.51M.